Keywords Diabetes Mellitus, Retinopathy, Neuropathy, Nephropathy, Cardiovascular Disease Share and Cite: Mohammed, S. , ...

For patients with ischemic stroke, tenecteplase seems to be a reasonable alternative to alteplase in terms of effectiveness and safety outcomes.

Who knew cutting your risk of stroke could be so convenient? Reviewed by Dietitian Karen Ansel, M.S., RDN "Key Takeaways" A ...

The risk of a full-blown stroke will remain high for at least a decade after a person has a slight brush with stroke, in the ...

A is a graph comparing the occurrence of ischemic stroke and major bleeding (cerebral hemorrhage, intestinal hemorrhage ...

On March 25, a jury handed down a $48 million verdict against St. Louis-based Mercy Hospital, Mercy Clinic and an obstetrician, siding with the family of a child left with brain damage after his birth ...

Imagine you're at a dinner party and the person sitting across the table from you suddenly stops making sense, and not ...

NeOnc Technologies Holdings, Inc. (to be listed on the NASDAQ Global Market under the symbol: NTHI), a clinical-stage medical biotechnology company, today announced the appointment of Dr. Steven L.

A new clot-busting drug for stroke works as well as a decades-old drug Patients given tenecteplase had similar outcomes to ...

Ali, H. , Ghaysaa, H. , Jaafar, W. and Malek, M. (2025) Ischemic Stroke Following Coronary Angiography: A Case Report. Case ...

The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent.

The 5-second intravenous bolus offers faster, simpler administration than Activase. (HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or ...